Combined and Triple Screening Tests vs NIPT: Comprehensive Comparison Guide
The Logic Behind Traditional Tests: "Probability" Calculations
Before NIPT technology, combined, triple, and quadruple screening tests were the best tools available. These are "traditional" or "biochemical" tests because they don't look directly at the baby's DNA.
Combined Screening Test (Weeks 11-14)
Two phases: ultrasound (nuchal translucency measurement) and blood (Beta-hCG and PAPP-A hormones). Accuracy for detecting Down Syndrome: 80-85%.
Triple and Quadruple Tests (Weeks 16-20)
Triple measures AFP, hCG, and Estriol. Quadruple adds Inhibin-A. Accuracy: 65-80%.
Two Major Problems with Traditional Tests
A. False Positives — Unnecessary Panic
Out of 100 women, 5 get "High Risk" results despite having completely healthy babies. They're sent into panic and forced into amniocentesis — while 95% of the time, the result comes back clean.
B. False Negatives — False Security
The test reports "Low Risk" while the baby actually has an anomaly. The family discovers the shock at birth.
NIPT: The Era of Certainty, Not Probability
- How it works: Reads the baby's DNA directly from the mother's blood starting at week 10.
- Perfect accuracy: Down, Edwards, and Patau detection at 99.9%.
- No false alarms: False positive rate below 0.1%.
- Early detection: From week 10.
Comparison Table
| Feature | Combined | Triple/Quad | NIPT |
|---|---|---|---|
| Timing | Weeks 11-14 | Weeks 16-20 | Week 10+ |
| Accuracy (Down) | 80-85% | 65-80% | 99.9% |
| False Positive | High (5%) | High | Below 0.1% |
Conclusion
With Omega Çare and Omega Genetik, you can avoid all this confusion. Test at home, analysis in a licensed lab with global partnerships.